Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Covalon TechnologiesCVALF +2.70%80 Operating Cash Flow per Share is $0.18 as of Jun. 2026. GuruFocus rates CVALF with a GF Score™ of 80/100 and a GF Value™ of $1.61 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 651 Medical Devices & Instruments companies, Covalon Technologies ranks worse than 153609.68% on this metric.
Covalon Technologies's operating cash flow per share for the
three
months ended in Jun. 2026 was $0.07.
Covalon Technologies's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2026 was $0.18.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Covalon Technologies was 29.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Covalon Technologies's Operating Cash Flow per Share or its related term are showing as below:
During the past 13 years, Covalon Technologies's highest 3-Year average Operating Cash Flow per Share Growth Rate was 79.60% per year. The lowest was -171.40% per year. And the median was 6.20% per year.
CVALF's 3-Year OCF Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 12.1 * Ranked among companies with meaningful 3-Year OCF Growth Rate only.
Covalon Technologies Operating Cash Flow per Share Related Terms
Covalon Technologies Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for Covalon Technologies's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Covalon Technologies Operating Cash Flow per Share Chart
CVALF vs ISRG, BDX, RMD: Operating Cash Flow per Share Comparison
For the Medical Instruments & Supplies subindustry, Covalon Technologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Covalon Technologies Price-to-Operating-Cash-Flow vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Covalon Technologies's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Covalon Technologies's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.18
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of $0.18 mean?
Covalon Technologies (CVALF) has a Operating Cash Flow per Share of $0.18 as of Jun. 2026. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Covalon Technologies and its competitors. According to the industry distribution chart, Covalon Technologies ranks #999999 out of 651 companies in the Medical Devices & Instruments industry.
Is Covalon Technologies' Operating Cash Flow per Share too high?
Covalon Technologies' current Operating Cash Flow per Share is $0.18. The Medical Devices & Instruments industry median Operating Cash Flow per Share is 12.10. Covalon Technologies' value of $0.18 is 98.5% below this industry median. Based on the distribution chart, Covalon Technologies ranks #999999 out of 651 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Covalon Technologies has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Covalon Technologies' Operating Cash Flow per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Covalon Technologies ranks #999999 out of 651 companies for Operating Cash Flow per Share. This places Covalon Technologies in the lower half of its industry. The industry median Operating Cash Flow per Share is 12.10. Covalon Technologies' value of $0.18 is 98.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Medical Devices & Instruments company?
The median Operating Cash Flow per Share among Medical Devices & Instruments companies is 12.10, based on 651 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Covalon Technologies's current Operating Cash Flow per Share of $0.18 is 98.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Covalon Technologies and its competitors. For the Medical Devices & Instruments industry, the median Operating Cash Flow per Share is 12.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Covalon Technologies's current Operating Cash Flow per Share is $0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Covalon Technologies stock overvalued right now?
Based on GuruFocus' analysis, Covalon Technologies (CVALF) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.61, compared to a current price of $2.21 — trading 37.3% above its estimated fair value. The current Operating Cash Flow per Share is $0.18 and 98.5% below the Medical Devices & Instruments industry median of 12.10. Covalon Technologies' overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For Covalon Technologies (CVALF), the current Operating Cash Flow per Share is $0.18 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Covalon Technologies (CVALF) Overvalued in 2026?
Based on GuruFocus' analysis, Covalon Technologies stock appears to be overvalued.
The current stock price of $2.21 is trading 37.3% above its estimated GF Value™ of $1.61.
GuruFocus considers Covalon Technologies to be Significantly Overvalued.
Key valuation signals for CVALF:
Operating Cash Flow per Share: $0.18
GF Value™: $1.61 vs. price of $2.21 (37.3% above fair value)
Industry Position: 98.5% below the Medical Devices & Instruments median (#999999 of 651)
No single metric tells the full story. See the CVALF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes in the areas of infection management, wound care, and surgical procedures. The company generates revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products include IV dressings, surgical site protection products, vascular access protection products, and others, and its solutions include primary dressing cover, vascular access technologies, advanced wound care, sensitive skin solutions, custom medical coatings, and patient resource support.
80GF Score
Get the complete analysis for CVALF
Operating Cash Flow per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVALF has been successfully added to your 
